Company Filing History:
Years Active: 2015
Title: Suhman Chung: Innovator in Retroviral Treatment
Introduction
Suhman Chung is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of retroviral infections. His innovative work has led to the development of compounds that hold promise in combating serious health issues.
Latest Patents
Suhman Chung holds 1 patent for his invention titled "Tropolone compounds for treating or preventing retroviral infection." This patent discloses compounds that inhibit RNase H activity of retroviruses. The compounds include a specific formula wherein R, R, and R are defined, along with pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs. The pharmaceutical compositions comprising these compounds are designed for the treatment or prevention of infections caused by the human immunodeficiency virus (HIV).
Career Highlights
Suhman Chung is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to engage in cutting-edge research and contribute to advancements in medical science.
Collaborations
Some of his notable coworkers include John A Beutler and Stuart F J LeGrice. Their collaborative efforts in research have further enhanced the impact of their work in the field of retroviral treatment.
Conclusion
Suhman Chung's innovative contributions to the treatment of retroviral infections exemplify the importance of research and development in the pharmaceutical industry. His work continues to pave the way for new therapeutic options for patients worldwide.